Irwin, James https://orcid.org/0000-0002-6804-1752
Lord, Anton
Ferguson, Emma
Simms, Lisa A.
Hanigan, Katherine
Montoya, Carlos A.
Radford-Smith, Graham
Funding for this research was provided by:
The University of Queensland
Article History
Received: 12 May 2022
Accepted: 20 July 2022
First Online: 20 September 2022
Declarations
:
: Authors have the following conflicts of interest to declare: GRS has worked on advisory boards for and received consulting fees from Abbvie, Janssen, Ferring, Takeda, and Amgen. JRI has received speaking fees from Janssen. AL, EF, CM, HK, and LS have no conflict of interest to declare.